<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04921150</url>
  </required_header>
  <id_info>
    <org_study_id>SMOCT</org_study_id>
    <nct_id>NCT04921150</nct_id>
  </id_info>
  <brief_title>Standardized Management of Complex Twins</brief_title>
  <official_title>Standardized Management of Complex Twins</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Caixia Liu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shengjing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shengjing Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      At present, the incidence of monochorionic twins in all pregnancies is around 3-5‰&#xD;
      worldwide.In 2019, the twin Committee of China Maternal and Child Health Association&#xD;
      conducted statistics from 48 medical units all over the country, showing that there were&#xD;
      4,876 cases of monochorionic twins, accounting for 10.2‰ of all pregnancies.In addition to&#xD;
      increased incidence of preterm delivery, miscarriage, and maternal complication, the unique&#xD;
      placental vascular structure of monochorionic twins is associated with complex fetal&#xD;
      complication such as twin-twin transfusion syndrome, selective intraurine growth restriction,&#xD;
      twin anaemia-erythrocytosis sequence, twin reversed arterial perfusion sequence, one of twin&#xD;
      with dysplasia, twins with single amniotic sac and conjunctions are common. At present, there&#xD;
      is no unified standard for the diagnosis and treatment of these complicated twins, and&#xD;
      various treatment methods have a great impact on the pregnancy outcome and fetal&#xD;
      prognosis.Therefore, the standardized management of complex twins benefits diagnosis and&#xD;
      treatment of complex twins and improves fetal prognosis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2021</start_date>
  <completion_date type="Anticipated">September 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Standardized management system of twin pregnancy clinic</measure>
    <time_frame>1 year</time_frame>
    <description>S/D score and Apgar score of complex twin pregnancy assessed by clinical doctors</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Twins</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standardization management</intervention_name>
    <description>Apply standardization management to improve the outcomes of pregnancy</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        complex twin disease 18-45 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        single pregnancy normal twin pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Caixia Liu, master</last_name>
    <phone>18804083801</phone>
    <email>liucx1716@163.com</email>
  </overall_contact>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 26, 2021</study_first_submitted>
  <study_first_submitted_qc>June 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 10, 2021</study_first_posted>
  <last_update_submitted>June 4, 2021</last_update_submitted>
  <last_update_submitted_qc>June 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Shengjing Hospital</investigator_affiliation>
    <investigator_full_name>Caixia Liu</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

